- Home
- BGLC vs NXGL Comparison
BGLC vs NXGL Comparison
Compare BGLC & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BGLC | NXGL |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4M | 4.9M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BGLC | NXGL |
|---|---|---|
| Price | $1.49 | $0.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 10.6K | ★ 567.9K |
| Earning Date | 04-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.78 | 24.00 |
| EPS | ★ N/A | N/A |
| Revenue | $7,424,911.00 | ★ $11,421,000.00 |
| Revenue This Year | N/A | $50.77 |
| Revenue Next Year | N/A | $46.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 31.46 |
| 52 Week Low | $1.07 | $0.30 |
| 52 Week High | $6.10 | $2.89 |
Technical Indicators
Market Signals| Indicator | BGLC | NXGL |
|---|---|---|
| Relative Strength Index (RSI) | 43.89 | 42.87 |
| Support Level | $1.22 | $0.32 |
| Resistance Level | $1.88 | $0.61 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 39.06 | 17.21 |
Price Performance
Historical ComparisonAbout BGLC BioNexus Gene Lab Corp
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.